论文部分内容阅读
为了解南京地区献血者中丙型肝炎病毒(HCV)的感染情况,我们对南京地区2002名献血者进行了抗-HCV 检测,同时对其它标志物进行了调查研究。2002名献血者中南京市区公民义务献血者(A 组)917人,本站朱林镇采血点(B 组)581人,汤山镇采血点(B 组)504人。试剂采用加拿大Yes 公司与中国输血研究所合作研制的抗-HCV 和抗-HIV 诊断血球;美国Chiron 公司的重组免疫印迹法(RIBA)HCV 诊断试剂;兰州生物制品研究所的HBsAg 诊断试剂;厦门新创科技有限公司的抗-HBc 酶联免疫诊断盒。结果与讨论:2002份标本中,抗-HCV 阳性20例(1.0%),其中A 组1例(0.1%),B 组8例(1.4%),C 组11例(2.2%)。20例抗-HCV 阳性标本进一步检
To understand the infection of hepatitis C virus (HCV) in blood donors in Nanjing, we tested anti-HCV in 2002 blood donors in Nanjing and investigated other markers. There were 917 blood donor donors (group A) in 2002 in Nanjing city, 581 blood donors (group B) and 504 blood donors (group B) in Zhu Town, Zhoushan Town. Reagents Canada-based Yes Company and the Chinese Institute of Blood Transfusion developed in cooperation with anti-HCV and anti-HIV diagnostic blood cells; the United States Chiron’s recombinant immunoblotting (RIBA) HCV diagnostic reagents; Lanzhou Institute of Biologicals HBsAg diagnostic reagents; Xiamen new Technology Co., Ltd. anti-HBc ELISA diagnostic box. Results and Discussion: Of the 2002 samples, 20 (1.0%) were positive for anti-HCV, including 1 in group A (0.1%), 8 in group B (1.4%) and 11 in group C (2.2%). 20 cases of anti-HCV positive specimens further examination